These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
333 related items for PubMed ID: 26951969
1. Comparison between patients with IgA nephropathy with minimal change disease and patients with minimal change disease. Li XW, Cheng SQ, Liang SS, Le WB, Zeng CH, Wang JQ, Liu ZH. Clin Nephrol; 2016 May; 85(5):273-81. PubMed ID: 26951969 [Abstract] [Full Text] [Related]
2. Long-term outcome of IgA nephropathy with minimal change disease: a comparison between patients with and without minimal change disease. Li XW, Liang SS, Le WB, Cheng SQ, Zeng CH, Wang JQ, Liu ZH. J Nephrol; 2016 Aug; 29(4):567-73. PubMed ID: 26537358 [Abstract] [Full Text] [Related]
3. Clinicopathologic features and treatment response in nephrotic IgA nephropathy with minimal change disease. Qin J, Yang Q, Tang X, Chen W, Li Z, Mao H, Jiang Z, Huang F, Yu X. Clin Nephrol; 2013 Jan; 79(1):37-44. PubMed ID: 22948116 [Abstract] [Full Text] [Related]
4. Mild mesangial proliferative IgA nephropathy with and without minimal change disease. Wang S, Huang B, Wang P, Liu Y, Liu Y, Chen H, Zhang J. Clin Exp Med; 2023 Dec; 23(8):5367-5376. PubMed ID: 37796359 [Abstract] [Full Text] [Related]
5. Clinical characteristics of concomitant nephrotic IgA nephropathy and minimal change disease in children. Shen H, Gu W, Mao J, Zhu X, Jin X, Fu H, Liu A, Shu Q, Du L. Nephron; 2015 Dec; 130(1):21-8. PubMed ID: 25924689 [Abstract] [Full Text] [Related]
6. IgA nephropathy with minimal change disease. Herlitz LC, Bomback AS, Stokes MB, Radhakrishnan J, D'Agati VD, Markowitz GS. Clin J Am Soc Nephrol; 2014 Jun 06; 9(6):1033-9. PubMed ID: 24721885 [Abstract] [Full Text] [Related]
7. Corticosteroid therapy in IgA nephropathy with minimal change-like lesions: a single-centre cohort study. Wang J, Juan C, Huang Q, Zeng C, Liu Z. Nephrol Dial Transplant; 2013 Sep 06; 28(9):2339-45. PubMed ID: 23787555 [Abstract] [Full Text] [Related]
8. Differences of clinicopathological characteristics and outcomes of IgA nephropathy patients with and without nephrotic syndrome. Huang N, Li J, Ai Z, Guo L, Chen W, Liu Q. Int Urol Nephrol; 2024 Sep 06; 56(9):3003-3011. PubMed ID: 38564075 [Abstract] [Full Text] [Related]
9. Clinical and pathological features of immunoglobulin A nephropathy patients with nephrotic syndrome. Han X, Xiao Y, Tang Y, Zheng X, Anwar M, Qin W. Clin Exp Med; 2019 Nov 06; 19(4):479-486. PubMed ID: 31542837 [Abstract] [Full Text] [Related]
10. A pilot and comparative study between pathological and serological levels of immunoglobulin and complement among three kinds of primary glomerulonephritis. Dong J, Peng T, Gao J, Jia X, Yan G, Wang Y. BMC Immunol; 2018 Jun 20; 19(1):18. PubMed ID: 29925312 [Abstract] [Full Text] [Related]
11. Pathological patterns of primary nephrotic syndrome in Central China: a retrospective study of 627 cases. Chu F, Chen G, Liu Y. Ren Fail; 2014 May 20; 36(4):514-9. PubMed ID: 24564431 [Abstract] [Full Text] [Related]
12. Reversal of active glomerular lesions after immunosuppressive therapy in patients with IgA nephropathy: a repeat-biopsy based observation. Shen XH, Liang SS, Chen HM, Le WB, Jiang S, Zeng CH, Zhou ML, Zhang HT, Liu ZH. J Nephrol; 2015 Aug 20; 28(4):441-9. PubMed ID: 25585823 [Abstract] [Full Text] [Related]
13. The Clinical Course of Minimal Change Nephrotic Syndrome With Onset in Adulthood or Late Adolescence: A Case Series. Maas RJ, Deegens JK, Beukhof JR, Reichert LJ, Ten Dam MA, Beutler JJ, van den Wall Bake AWL, Rensma PL, Konings CJ, Geerse DA, Feith GW, Van Kuijk WH, Wetzels JF. Am J Kidney Dis; 2017 May 20; 69(5):637-646. PubMed ID: 28089478 [Abstract] [Full Text] [Related]
14. Spontaneous remission of nephrotic syndrome in patients with IgA nephropathy. Han SH, Kang EW, Park JK, Kie JH, Han DS, Kang SW. Nephrol Dial Transplant; 2011 May 20; 26(5):1570-5. PubMed ID: 20841490 [Abstract] [Full Text] [Related]
15. Mycophenolate mofetil therapy for steroid-resistant IgA nephropathy with the nephrotic syndrome in children. Kang Z, Li Z, Duan C, Wu T, Xun M, Ding Y, Zhang Y, Zhang L, Yin Y. Pediatr Nephrol; 2015 Jul 20; 30(7):1121-9. PubMed ID: 25773534 [Abstract] [Full Text] [Related]
16. Expression of DENDRIN in several glomerular diseases and correlation to pathological parameters and renal failure - preliminary study. Mizdrak M, Vukojević K, Filipović N, Čapkun V, Benzon B, Durdov MG. Diagn Pathol; 2018 Nov 20; 13(1):90. PubMed ID: 30458823 [Abstract] [Full Text] [Related]
17. Clinicopathological features, diagnosis, and treatment of IgA nephropathy with minimal change disease related to exposure to mercury-containing cosmetics: a case report . Niu HX, Li SH, Li HY, Chen YH, Liu WW, Li PL, Long HB. Clin Nephrol; 2017 Apr 20; 87 (2017)(4):196-201. PubMed ID: 28102816 [Abstract] [Full Text] [Related]
18. Acthar gel in the treatment of nephrotic syndrome: a multicenter retrospective case series. Madan A, Mijovic-Das S, Stankovic A, Teehan G, Milward AS, Khastgir A. BMC Nephrol; 2016 Mar 31; 17():37. PubMed ID: 27036111 [Abstract] [Full Text] [Related]
19. Key pathological features characterize minimal change disease-like IgA nephropathy. Wang TY, Chang FP, Yang AH, Ka SM, Chen A, Hsieh JT, Chen FY, Lee TL, Tseng PY, Tsai MT, Li SY, Yang CY, Chen JY, Lin CC, Tarng DC. PLoS One; 2023 Mar 31; 18(7):e0288384. PubMed ID: 37471324 [Abstract] [Full Text] [Related]
20. Characteristics of IgA nephropathy in advanced-age patients. Oshima Y, Moriyama T, Itabashi M, Takei T, Nitta K. Int Urol Nephrol; 2015 Jan 31; 47(1):137-45. PubMed ID: 25388352 [Abstract] [Full Text] [Related] Page: [Next] [New Search]